DiGinnovation: Supporting digital health micro and small enterprises on their way to reimbursement

Commercialising entities of the solution that:

• Are a for-profit micro or small enterprise according to the EU definition.
• Are legally incorporated in the EU or Horizon Europe-associated countries.
• Have at least 4 paid FTEs working at the time of the short proposal submission.
• Have a CEO working full-time in the company at the time of the short proposal submission.
• The entity cannot have publicly traded shares or gone through an IPO.
• Meet the requirements for the reimbursable app in the targeted market.
• Have a CE-marked digital health device that is patient-centred and classified as class I-IIa, or in the case of France as the targeted market, also class IIb, at the time of the short proposal submission.
• Are applying for at least €150,000 EIT Health grant.
• Have a digital health device with maturity level IML7 (validation of solution) or IML8 (approval and launch) at the beginning of the project with the aim to move to reimbursement, and IML9 (clinical use) by a maximum 1 year following the end of the project, according to CIMIT Healthcare Innovation Cycle.
• The consortium must be complete at the time of submission.
  • Each consortium must have at least one EIT Health member of the association as part of the consortium (Core or Associate Partner).
  • Each consortium must include participants residing in at least two eligible countries, participating through two different Co-Location Centres (CLCs).

EIT Health is committing to support the development of the selected micro and small enterprises by granting funds and in-kind contributions to support innovation activities of a project. In return, EIT Health shall participate in the enterprise by way of receiving options to assume shares in the enterprise upon the occurrence of pre-defined Exit Events.

The commercial entity is required to formulate a proposal that aligns with the stipulated requirements outlined in this call. Intellectual Property is owned by the consortium.

The “Grant to Options” model is designated as the financial sustainable model for micro and small enterprises responsible for introducing the product or service to the market. Please find further information about the “Grant to Options” model here.

Attend to the EIT Health MatchMaking event in Santanter (Spain) on 8 and 9 of November to learn everything about the programme and to connect with relevant partners for your consortium.
Find out more

Applications to DiGinnovation are currently closed. Be the first to know about upcoming programmes and opportunities that may be a good fit for you by joining our mailing list.

The DiGinnovation programme is an activity included in the EIT Health’s Flagship Call BP2025. For more information on the call and the programme, please visit EIT Health Flagships.